The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia

Rivka Yatuv, Micah Robinson, Inbal Dayan-Tarshish, Moshe BaruOmri Laboratories Ltd., Nes Ziona, IsraelAbstract: Hemophilia A is a rare X-linked bleeding disorder caused by lack or dysfunction of coagulation factor VIII (FVIII). Hemophilia A is treated with replacement therapy, but frequent injection...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rivka Yatuv, Micah Robinson, Inbal Dayan-Tarshish, et al
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://doaj.org/article/4715a0a1ae424948968807094c17044f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!